Evaluation of Antimicrobial Peptide-Antibiotic Combination Treatment for Tackling Ocular and Systemic <i>Staphylococcus aureus</i> Infections. [PDF]
Barahim EK +10 more
europepmc +1 more source
Susceptibility-Guided Versus Empirical Therapy for Helicobacter pylori Infection in a High Resistance Setting: A Randomised Controlled Trial. [PDF]
Lu K +11 more
europepmc +1 more source
Clinical Profile of Children With Typhoid and Paratyphoid Fever and Antimicrobial Susceptibility Testing Patterns of the Bacterial Isolates: A Cross-Sectional Study. [PDF]
Behera CK +5 more
europepmc +1 more source
Clinical application and safety observation of levofloxacin in children with refractory Mycoplasma pneumoniae pneumonia. [PDF]
Li T, Zhao L, Lang X, Li Q, Yu L.
europepmc +1 more source
Retained Stingray Barb in the Sole of the Foot. [PDF]
Sakamoto S.
europepmc +1 more source
In Vitro Activity of Imipenem-Funobactam Against Clinical Isolates of Gram-Negative Bacilli. [PDF]
Karlowsky JA +5 more
europepmc +1 more source
Late-Onset <i>Salmonella</i> Abscess of a Silicone Breast Implant Presenting 40 Years After Augmentation. [PDF]
Schackmuth B +3 more
europepmc +1 more source
Levofloxacin in veterinary medicine: a literature review [PDF]
A potent third-generation antimicrobial fluoroquinolone drug, levofloxacin was introduced into human clinical practice in 1993. Levofloxacin is also used in veterinary medicine, however its use is limited: it is completely banned for veterinary use in ...
Irène Sartini +2 more
exaly +2 more sources
Synthesis and Evaluation of Antimicrobial Activity of [R4W4K]-Levofloxacin and [R4W4K]-Levofloxacin-Q Conjugates [PDF]
The development of a new class of antibiotics to fight bacterial resistance is a time-consuming effort associated with high-cost and commercial risks. Thus, modification, conjugation or combination of existing antibiotics to enhance their efficacy is a ...
Keykavous Parang, Rakesh Tiwari
exaly +2 more sources

